2 recruiting, 1 not yet recruiting, 1 withdrawn. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Not yet recruiting 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Graft -Versus-host-disease: new trials by email Literature Review of Graft -Versus-host-disease trials Research Report on Graft -Versus-host-disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation Hematopoietic Cell Transplantation, Cyclophosphamide, Tacrolimus - Graft -Versus-host-disease | Phase 2 | Not yet recruiting | Medical College of Wisconsin | 72 | 2026-11-01 | 2026-09-08 |
| Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL Total Body Irradiation 8 Gy, Ruxolitinib, Blinatumomab - Acute Lymphoblastic Leukemia (ALL), Stem Cell Transplant | Phase 2 / Phase 3 | Recruiting | Bambino Gesù Hospital and Research Institute | 1000 | 2026-01-07 | 2026-10-20 |
| BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation BPC-2001 - Graft -Versus-host-disease, aGVHD | Phase 2 | Recruiting | BioPhoenix Co., Ltd. | 50 | 2025-10-29 | 2026-08-17 |
| Mesenchymal Stem Cells as a Treatment for Oral Complications of Graft-versus-host Disease Mesenchymal stromal cells - Graft -Versus-host-disease | Phase 1 / Phase 2 | Withdrawn | Karolinska Institutet | 2014-01-01 | 2019-08-14 |
Graft vs Host Disease (4) · Hematologic Neoplasms (1) · Immune System Diseases (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Immune System Diseases (3) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Cyclophosphamide (2) · Adrenal Cortex Hormones (1) · KRN 7000 (1) · Mycophenolic Acid (1) · Stem Cell Transplantation (1) · Tacrolimus (1) · axatilimab (1) · blinatumomab (1) · ruxolitinib (1)
Bambino Gesù Hospital and Research Institute (1) · BioPhoenix Co., Ltd. (1) · Karolinska Institutet (1) · Medical College of Wisconsin (1)
Austria (1) · China (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Italy (1) · Norway (1) · Poland (1) · Sweden (1) · United States (1)
Franco Locatelli, Professor (1) · Karin Garming-Legert, DDS, PhD (1) · Katarina Le Blanc, Professor (1) · Mehdi Hamadani, MD (1) · Rachael Sugars, BSc, PhD (1) · Sameem Abedin, MD (1) · Xiaodong Mo, PhD (1)
2025 (1)